ClinicalTrials.govpublic full text
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
small-cell lung cancer, neuroendocrine carcinomas, solid tumor show to express dll3, ide849, small cell lung cancer, sclc, anti-dll3 immunoglobulin g1 monoclonal antibody, dll3, nec, durvalumab, ide161, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825503
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.